Cargando…

PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series

Case 1 (TTD 30yrs): 71-year-old female presented with decreased mobility over the past 15years. She had malformations of the great toes. She developed "golf ball" sized calcified lumps in the upper ribs, clavicle and sternum which began to form at the age of 32 and were removed surgically....

Descripción completa

Detalles Bibliográficos
Autores principales:	Almonaei, Khulod, M’Hiri, Iman, Al-Ali, Dalal, Dandurand, Karel, Khan, Aliya A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Bone & Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624679/ http://dx.doi.org/10.1210/jendso/bvac150.415

Ejemplares similares

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

THU467 Pharmacokinetics And Pharmacodynamics Of Garetosmab In Patients With Fibrodysplasia Ossificans Progressiva
por: Wang, Yuhuan, et al.
Publicado: (2023)

RF18 | PSAT149 Joint Function and Quality of Life in Fibrodysplasia Ossificans Progressiva: Results from an International Burden of Illness Survey of Patients and Family Members
por: Böing, Elaine A, et al.
Publicado: (2022)

SUN-344 Patients with Fibrodysplasia Ossificans Progressiva Have an Increased Prevalence of Cardiac Conduction Abnormalities
por: Kou, Samuel, et al.
Publicado: (2020)

MON-348 Surgical Management of Bilateral Hip Fracture in a Patient with Fibrodysplasia Ossificans Progressiva Treated with Palovarotene
por: Singh, Sukhmani, et al.
Publicado: (2020)

OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
por: Dahir, Kathryn M, et al.
Publicado: (2023)

ODP108 Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Phase III Open-Label PIVOINE Rollover Trial
por: Artyomenko, Alex, et al.
Publicado: (2022)

THU402 New Heterotopic Ossification Lesions In Patients With Fibrodysplasia Ossificans Progressiva Measured By PET/CT vs CT Only
por: Trotter, Dinko Gonzalez, et al.
Publicado: (2023)

ODP103 IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Randomized, Double-Blind, Placebo-Controlled Phase II FALKON Trial
por: Karimian, Negar, et al.
Publicado: (2022)

THU460 A Case Series Of Hypophosphatasia: Presentation And Response To Asfotase Alfa
por: Alsarraf, Farah, et al.
Publicado: (2023)

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
por: Pignolo, Robert J., et al.
Publicado: (2020)

Clinical, evolution and therapeutical considerations upon a case of fibrodysplasia ossificans progressiva (FOP)
por: Rogoveanu, O, et al.
Publicado: (2013)

PSAT201 Hypoparathyroidism (HypoPT) in 16 Pregnancies in 7 Patients: A Case Series of Maternal and Neonatal Outcomes
por: Ali, Dalal S, et al.
Publicado: (2022)

Atypical Presentation of Familial Hypocalciuric Hypercalcemia: Case Report
por: Ali, Dalal S, et al.
Publicado: (2021)

Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

Delayed Diagnosis of Congenital Hypoparathyroidism in a Kindred of Three Patients With Autosomal Dominant Deafness
por: Dandurand, Karel, et al.
Publicado: (2021)

Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
por: Padilha, Elias C., et al.
Publicado: (2019)

Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective
por: Pignolo, Robert J., et al.
Publicado: (2022)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

Longitudinal Evaluation of Pain, Flare‐Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry
por: Peng, Ke, et al.
Publicado: (2019)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases
por: Baujat, Geneviève, et al.
Publicado: (2017)

Recent Topics in Fibrodysplasia Ossificans Progressiva
por: Katagiri, Takenobu, et al.
Publicado: (2018)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization
por: Pignolo, Robert J., et al.
Publicado: (2021)

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)

Quality of life of patients with fibrodysplasia ossificans progressiva
por: Ortiz-Agapito, Fernando, et al.
Publicado: (2015)

Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva
por: Colmenares-Bonilla, Douglas, et al.
Publicado: (2018)

Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
por: Khan, Fatima, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis
por: De Brasi, Daniele, et al.
Publicado: (2021)

PSAT216 Turner Syndrome and Congenital Hypoparathyroidism
por: Jovanovic, Filip, et al.
Publicado: (2022)

PSAT228 Hereditary Hypophosphatemic Rickets: Management in Adults
por: Manas, F N U, et al.
Publicado: (2022)

PSAT193 Skeletal Fluorosis due to Inhalant Abuse
por: Pedraza, Lina, et al.
Publicado: (2022)

PSAT209 A Remission of Hypocalcemia in Idiopathic Hypoparathyroidism
por: Puzio, Helene, et al.
Publicado: (2022)

PSAT224 Endocrine Manifestations in Diamond Blackfan Anemia
por: Shah, Anvay, et al.
Publicado: (2022)

PSAT212 Hyperparathyroidism Secondary to Ectopic Parathyroid Adenoma
por: Sy, Katrina Vina, et al.
Publicado: (2022)

Fibrodysplasia Ossificans Progressiva: A Case Series with Radiologic Findings
por: Malik, Ipanshu, et al.
Publicado: (2022)

PSAT196 Monostotic Paget's disease of the bone involving the calcaneus
por: Eldin, Randa Sharag, et al.
Publicado: (2022)

PSAT188 Keeping An Eye On Bisphosphonates: Drug Induced Uveitis
por: Ataallah, Basma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nbfv02umhv2fh55hivufr8cm49